A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab [Corrigendum]
Megna M, Ruggiero A, Salsano A, et al. Clin Cosmet Investig Dermatol. 2023;16:3503–3507. The authors have advised that the study did not receive any funding. The funding statement “Medical writing was funded through a donation by Abbvie Srl” on page 3506 should be removed. The authors apologize for...
Saved in:
Main Authors: | Megna M (Author), Ruggiero A (Author), Salsano A (Author), Lauletta G (Author), Portarapillo A (Author), Torta G (Author), Martora F (Author), Potestio L (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab
by: Megna M, et al.
Published: (2023) -
Risk Factors for Psoriasis Flares: A Narrative Review
by: Potestio L, et al.
Published: (2024) -
Biologics for the Management of Erythrodermic Psoriasis: An Updated Review
by: Potestio L, et al.
Published: (2023) -
Erythrodermic Psoriasis Managed with Risankizumab
by: Abdulmajeed Alajlan, et al.
Published: (2022) -
Guselkumab, Risankizumab, and Tildrakizumab in the Management of Psoriasis: A Review of the Real-World Evidence
by: Ruggiero A, et al.
Published: (2022)